SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-23-000252
Filing Date
2023-02-14
Accepted
2023-02-14 15:32:55
Documents
1
Group Members
ANUPAM DALAL

Document Format Files

Seq Description Document Type Size
1 vistagen13ga3.htm SC 13G/A 78470
  Complete submission text file 0000935836-23-000252.txt   80207
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Subject) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-86249 | Film No.: 23628001
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1301 SHOREWAY ROAD SUITE 350 BELMONT CA 94002
Business Address 1301 SHOREWAY ROAD SUITE 350 BELMONT CA 94002 650-529-8000
ACUTA CAPITAL PARTNERS, LLC (Filed by) CIK: 0001582844 (see all company filings)

IRS No.: 452817402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A